Treatment with Aromatase Inhibitors

Serdar E. Bulun, Bilgin Gürateş, Zongjuan Fang, Mitsutoshi Tamura, David Langoi, Gonca İmir, Sanober Amin, Santanu Deb, Sijun Yang
In: Endometriosis · 2003 · pp. 189–202 · doi:10.1201/b14235-12 · W2480867097
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This paper details the mechanism of action and clinical applications of aromatase inhibitors, a class of drugs used primarily in the treatment of hormone-receptor-positive breast cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (28)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK